Traditional Chinese medicine composition for treating phlegm stagnation and blockage type vascular dementia after cerebral arterial thrombosis

Abstract

The invention relates to a traditional Chinese medicine composition for treating phlegm stagnation and blockage type vascular dementia after cerebral arterial thrombosis, which belongs to the technical field of medicine. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicines in parts by weight: 5 to 13 parts of latouchea fokiensis, 4 to 8 parts of aralia undulata, 4 to 8 parts of irkutsk anemone rhizome, 4 to 8 parts of loranthus parasiticus, 4 to 8 parts of benzoin, 4 to 8 parts of calamus, 4 to 8 parts of grewia biloba, 4 to 8 parts of calystegia hederacea, 4 to 8 parts of ramin, 4 to 8 parts of pericarp of sterculia nobilis, 4 to 8 parts of Lanjiang lily bulb and 4 to 8 parts of liquorice. All of the medicines are combined, so as to achieve the effects of promoting blood circulation, dispersing blood stasis, eliminating phlegm, activating the brain, restoring consciousness and calming nerves, and clinical symptoms and signs of patients with the phlegm stagnation and blockage type vascular dementia after the cerebral arterial thrombosis can be obviously improved.

Description

technical field

[0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type. Background technique

[0002] Vascular dementia (VasculardementiaVD) is a severe cognitive impairment syndrome caused by cerebrovascular disease. Ischemic stroke (IschemicstrokeIS) is one of the main cerebrovascular diseases leading to VD, and the incidence of VD after IS has been reported in 18.2% to 34.2%. Western medicine currently mainly relies on methods such as improving cerebral circulation and nourishing cranial nerves to treat vascular dementia, but its clinical treatment effect is not ideal. Contents of the invention

[0003] The technical problem to be solved by the present invention is to avoid the disadvantages of the above-mentioned prior art, and to provide a traditional Chinese medicine composition for treating post-ischemi...

Examples

Embodiment 1

[0038] A traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type, the weight ratio of each raw material is as follows:

[0039] 9g Spoonleaf Grass, 6g Aralia japonica, 6g Iris Calamus, 6g Masang Parasitic, 6g Benzoin, 6g White Calamus, 6g Pole, 6g Dawanhua, 6g White Wood, 6g Water Hyacinth Shell, 6g Lanjiang Lily , licorice 6g.

Embodiment 2

[0041] A traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type, the weight ratio of each raw material is as follows:

[0042] 7 parts of Spoonleaf Grass, 5 parts of Aralia japonica, 5 parts of Iris, 5 parts of Masang parasite, 5 parts of benzoin, 5 parts of white calamus, 5 parts of pole, 5 parts of Dawanhua, 5 parts of white wood, phoenix 5 parts of eye shell, 5 parts of Lanjiang lily, 5 parts of licorice.

Embodiment 3

[0044] A traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type, the weight ratio of each raw material is as follows:

[0045] 13 parts of Spoonleaf Grass, 7 parts of Aralia japonica, 7 parts of Iris, 7 parts of Masang parasitic, 7 parts of benzoin, 7 parts of white calamus, 7 parts of pole, 7 parts of Dawanhua, 7 parts of white wood, phoenix 7 parts of eye shell, 7 parts of Lanjiang lily, 7 parts of licorice.

technical field

[0001] The invention belongs to the technical field of medicine, and in particular relates to a traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type. Background technique

[0002] Vascular dementia (VasculardementiaVD) is a severe cognitive impairment syndrome caused by cerebrovascular disease. Ischemic stroke (IschemicstrokeIS) is one of the main cerebrovascular diseases leading to VD, and the incidence of VD after IS has been reported in 18.2% to 34.2%. Western medicine currently mainly relies on methods such as improving cerebral circulation and nourishing cranial nerves to treat vascular dementia, but its clinical treatment effect is not ideal. Contents of the invention

[0003] The technical problem to be solved by the present invention is to avoid the disadvantages of the above-mentioned prior art, and to provide a traditional Chinese medicine composition for treating post-ischemi...

Examples

Embodiment 1

[0038] A traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type, the weight ratio of each raw material is as follows:

[0039] 9g Spoonleaf Grass, 6g Aralia japonica, 6g Iris Calamus, 6g Masang Parasitic, 6g Benzoin, 6g White Calamus, 6g Pole, 6g Dawanhua, 6g White Wood, 6g Water Hyacinth Shell, 6g Lanjiang Lily , licorice 6g.

Embodiment 2

[0041] A traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type, the weight ratio of each raw material is as follows:

[0042] 7 parts of Spoonleaf Grass, 5 parts of Aralia japonica, 5 parts of Iris, 5 parts of Masang parasite, 5 parts of benzoin, 5 parts of white calamus, 5 parts of pole, 5 parts of Dawanhua, 5 parts of white wood, phoenix 5 parts of eye shell, 5 parts of Lanjiang lily, 5 parts of licorice.

Embodiment 3

[0044] A traditional Chinese medicine composition for treating post-ischemic stroke vascular dementia of phlegm-stasis-blocking type, the weight ratio of each raw material is as follows:

[0045] 13 parts of Spoonleaf Grass, 7 parts of Aralia japonica, 7 parts of Iris, 7 parts of Masang parasitic, 7 parts of benzoin, 7 parts of white calamus, 7 parts of pole, 7 parts of Dawanhua, 7 parts of white wood, phoenix 7 parts of eye shell, 7 parts of Lanjiang lily, 7 parts of licorice.